The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
Open accessAbstract
The glucose transporter GLUT1 at the blood-brain barrier (BBB) mediates glucose transport into the brain. Alzheimer's disease is characterized by early reductions in glucose transport associated with diminished GLUT1 expression at the BBB. Whether GLUT1 reduction influences disease pathogenesis remains, however, elusive. Here we show that GLUT1 deficiency in mice overexpressing amyloid β-peptide (Aβ) precursor protein leads to early cerebral microvascular degeneration, blood flow reductions and dysregulation and BBB breakdown, and to accelerated amyloid β-peptide (Aβ) pathology, reduced Aβ clearance, diminished neuronal activity, behavioral deficits, and progressive neuronal loss and neurodegeneration that develop after initial cerebrovascular degenerative changes. We also show that GLUT1 deficiency in endothelium, but not in astrocytes, initiates the vascular phenotype as shown by BBB breakdown. Thus, reduced BBB GLUT1 expression worsens Alzheimer's disease cerebrovascular degeneration, neuropathology and cognitive function, suggesting that GLUT1 may represent a therapeutic target for Alzheimer's disease vasculo-neuronal dysfunction and degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Slc2a1 + / -mice with haploid deficiency in glucose transporter GLUT1 in brain endothelial cells develop microvascular reductions with BBB breakdown including loss of TJ and basement membrane proteins (649), whereas knockout of murine Mfsd2a gene results in not only diminished brain uptake of docosahexaenoic acid (DHA) in the form of lysophosphatidylcholine, but also leads to dysregulated cave”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since glucose concentration is lower in the brain interstitial fluid (ISF) compared with plasma, GLUT1 favors blood-to-brain transport of circulating glucose (141, 390, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glut1 + / -mice phenocopy human pathology, and develop initially within 2-3 wk of age BBB breakdown with loss of tight junctions and diminished glucose uptake by the brain, which is followed by microvascular regression, reduced brain perfusion and development of secondary neurodegenerative changes, microcephaly, and loss of cortical and hippocampal neurons (649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experimental studies also support diminished transport of 14 C-labeled glucose across the BBB in haploinsufficient Slc2a1 + / -mice lacking ~50% copies of the GLUT1 BBB transporter (649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Reduced activity and expression of the GLUT-1 transporter in the BBB suggest decreased glucose uptake and utilization by the brain,360,363 which may further exacerbate cerebrovascular degeneration, BBB breakdown, and Aβ pathology in models overexpressing APP, inducing neurodegeneration and cognitive deficits (Fig. 4).364”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [364]
The cited source says what the claim attributes to it.
In the citing paper
“reduced GLUT1 levels may also inhibit LRP1 transcriptionally via sterol regulatory element binding protein 2 (SREBP2) (649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
The cited source says what the claim attributes to it.
In the citing paper
“Brain endothelial specific or enriched transporters are often indispensable for BBB barriergenesis, as for example, the glucose transporter-1 (GLUT1) (649), sodium-dependent lysophosphatidylcholine (LPC) symporter, the major facilitator superfamily (MFS) domain-containing protein 2a (MFSD2A) (62), and monocarboxylic acid transporter MCT8 (611).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
The cited source says what the claim attributes to it.
In the citing paper
“Since glucose concentration is lower in the brain interstitial fluid (ISF) compared with plasma, GLUT1 favors blood-to-brain transport of circulating glucose (141, 390, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
The cited source says what the claim attributes to it.
In the citing paper
“GLUT1 is expressed in endothelial cells, but not in neurons (141, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
The cited source says what the claim attributes to it.
In the citing paper
“For example, LRP1 minigene delivery to the BBB by viral vectors facilitates A 𝛃 clearance and attenuates A 𝛃 pathology (649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
The cited source says what the claim attributes to it.
In the citing paper
“which we know leads to severe neurological phenotype in the GLUT1-deficiency syndrome (630, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [649]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
Self-citationRetractedCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Self-citationRAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293
Self-citationAssessing nest building in mice
Deacon, R. M. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.170 · Cited by 1,115
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
Nguyen, L. N., Ma, D., Shui, G., Wong, P., Cazenave-Gassiot, A., Zhang, X., Wenk, M. R., Goh, E. L. K., & Silver, D. L. (2014) · Nature · doi:10.1038/nature13241 · Cited by 1,048
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 682
Akao, Y., Kuranaga, Y., Heishima, K., Sugito, N., Morikawa, K., Ito, Y., Soga, T., & Ito, T. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108922 · Cited by 32
Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading
Ishibashi, K., Wagatsuma, K., Ishiwata, K., & Ishii, K. (2016) · Human Brain Mapping · doi:10.1002/hbm.23210 · Cited by 32
ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology
Cao, Y., Xu, H., Zhu, Y., Shi, M.-J., Wei, L., Zhang, J., Cheng, S., Shi, Y., Tong, H., Kang, L., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000313 · Cited by 31
RetractedBlood brain barrier dysfunction in healthy aging and dementia: Why, how, what for?
Cunha, S., Bicker, J., Sereno, J., Falcão, A. C., & Fortuna, A. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102395 · Cited by 31
Rojas-Pirela, M., Andrade-Alviárez, D., Rojas, V., Marcos, M., Salete-Granado, D., Chacón-Arnaude, M., Pérez-Nieto, M. Á., Kemmerling, U., Concepción, J. L., Michels, P. A. M., et al. (2025) · Open Biology · doi:10.1098/rsob.240239 · Cited by 31
Vogelsang, P., Giil, L. M., Lund, A., Vedeler, C. A., Parkar, A. P., Nordrehaug, J. E., & Kristoffersen, E. K. (2017) · Brain Research · doi:10.1016/j.brainres.2017.10.035 · Cited by 31
Gut Microbiota Metabolite Fights Against Dietary Polysorbate 80-Aggravated Radiation Enteritis
Li, Y., Xiao, H., Dong, J., Luo, D., Wang, H., Zhang, S., Zhu, T., Zhu, C., Cui, M., & Fan, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01450 · Cited by 32
Söderbom, G., & Zeng, B. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.023 · Cited by 32
Menet, R., Bourassa, P., Calon, F., & ElAli, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104881 · Cited by 31
Fan, F. (2017) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2017.02.555587 · Cited by 31
Effect of AceK (acesulfame potassium) on brain function under dietary restriction in mice
Ibi, D., Suzuki, F., & Hiramatsu, M. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.02.024 · Cited by 32
Travica, N., Ried, K., Hudson, I. L., Sali, A., Scholey, A. B., & Pipingas, A. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00047 · Cited by 31
Nanomedicine based strategies for oligonucleotide traversion across the blood–brain barrier
Amulya, E., Sikder, A., Vambhurkar, G. B., Shah, S., Khatri, D. K., Raghuvanshi, R. S., Singh, S. B., & Srivastava, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.031 · Cited by 30
Tarawneh, R. (2023) · Biomolecules · doi:10.3390/biom13050830 · Cited by 29
Cao, B., Zeng, M., Hao, F.-X., Hao, Z., Zhang, Z.-K., Liang, X.-W., Wu, Y., Zhang, Y., Feng, W., & Zheng, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115825 · Cited by 30
Salcedo, C., Garcia, V. P., García‐Adán, B., Ameen, A. O., Gegelashvili, G., Waagepetersen, H. S., Freude, K., & Aldana, B. I. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16014 · Cited by 30
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
Sharif, A., Mamo, J. C. L., Lam, V., Al‐Salami, H., Mooranian, A., Watts, G. F., Clarnette, R., Luna, G., & Takechi, R. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00398-w · Cited by 29
Transcellular Barriers to Glucose Delivery in the Body
Klip, A., Bock, K. D., Bilan, P. J., & Richter, E. A. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-031657 · Cited by 30
Sullivan, J. M., Bagnell, A. M., Alevy, J., Avila, E. M., Mihaljević, L., Saavedra-Rivera, P. C., Kong, L., Huh, J. S., McCray, B. A., Aisenberg, W. H., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk1358 · Cited by 29
Self-citationMarko, D. M., Foran, G., Vlavcheski, F., Baron, D. C., Hayward, G. C., Baranowski, B. J., Necakov, A., Tsiani, E., & MacPherson, R. E. K. (2020) · Cells · doi:10.3390/cells9051114 · Cited by 30
Solarz, A., Majcher‐Maślanka, I., & Chocyk, A. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22846 · Cited by 29
Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C
Huuskonen, M. T., Wang, Y., Nikolakopoulou, A. M., Montagne, A., Dai, Z., Lazić, D., Sagare, A. P., Zhao, Z., Fernández, J. A., Griffin, J. H., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211372 · Cited by 30
Self-citationVascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease
Tarawneh, R. M., Kasper, R. S., Sanford, J., Phuah, C., Hassenstab, J. J., & Cruchaga, C. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51685 · Cited by 29
Kisler, K., Sagare, A. P., Lazić, D., Bazzi, S. A., Lawson, E. J., Hsu, C.-J., Wang, Y., Ramanathan, A., Nelson, A. R., Zhao, Z., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00597-5 · Cited by 29
Self-citationLiu, J., van Beusekom, H. M. M., Bu, X., Chen, G., Rosado-de-Castro, P. H., Chen, X., Chen, X., Clarkson, A. N., Farr, T. D., Fu, Y., et al. (2023) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.23 · Cited by 32
Meox2 haploinsufficiency increases neuronal cell loss in a mouse model of Alzheimer's disease
Soto, I., Grabowska, W. A., Onos, K. D., Graham, L. C., Jackson, H. M., Simeone, S. N., & Howell, G. R. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.025 · Cited by 32
Katsel, P., Roussos, P., Beeri, M. S., Gama-Sosa, M. A., Gandy, S., Khan, S., & Haroutunian, V. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206547 · Cited by 29
Zhang, Y., Bi, K., Zhou, L., Wang, J., Huang, L., Sun, Y., Peng, G., & Wu, W. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s471174 · Cited by 30
Harnessing BDNF Signaling to Promote Resilience in Aging
Faraji, J., & Metz, G. A. S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0961 · Cited by 29
Kang, X., Su, S., Hong, W., Geng, W., & Tang, H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.755902 · Cited by 28
“Liquid Biopsy” of White Matter Hyperintensity in Functionally Normal Elders
Elahi, F. M., Casaletto, K. B., Altendahl, M., Staffaroni, A. M., Fletcher, E. M., Filshtein, T. J., Glymour, M. M., Miller, B. L., Hinman, J. D., DeCarli, C. S., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00343 · Cited by 28
Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice
Hoyk, Z., Tóth, M. E., Lénárt, N., Nagy, D., Dukay, B., Csefová, A., Zvara, Á., Seprényi, G., Kincses, A., Walter, F. R., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00380 · Cited by 28
Non‐genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells
Boscaro, C., Carotti, M., Albiero, M., Trenti, A., Fadini, G. P., Trevisi, L., Sandonà, D., Cignarella, A., & Bolego, C. (2020) · The FASEB Journal · doi:10.1096/fj.202001130r · Cited by 27
Du, Y.-H., Yang, R., Wang, Q., Wang, L., Liang, L., Zhu, L., Sun, Y., & Cai, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.670220 · Cited by 27
Effect of retinoic acid on the neurovascular unit: A review
Pouso, M. R., & Cairrão, E. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.03.011 · Cited by 27
An oxygen-adaptive interaction between SNHG12 and occludin maintains blood-brain barrier integrity
Li, Y., Wei, J., Liu, H., Wang, K.-J., Jin, S.-N., Su, Z.-K., Wang, H., Shi, J.-X., Li, B., Shang, D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110656 · Cited by 27
Glycogen metabolism is impaired in the brain of male type 2 diabetic Goto‐Kakizaki rats
Soares, A. F., Nissen, J. D., García-Serrano, A. M., Nussbaum, S. S., Waagepetersen, H. S., & Duarte, J. M. N. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24437 · Cited by 27
The Blood–Brain Barrier: Much More Than a Selective Access to the Brain
Sánchez-Cano, F., Hernández‐Kelly, L. C., & Ortega, A. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00431-0 · Cited by 30
Cisternas, P., Gherardelli, C., Gutiérrez, J., Salazar, P. L., Méndez‐Orellana, C., Wong, G. W., & Inestrosa, N. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1237796 · Cited by 26
Accumulation of minor alleles and risk prediction in schizophrenia
He, P., Lei, X., Yuan, D., Zhu, Z., & Huang, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12104-0 · Cited by 26
Astrocytic transporters in Alzheimer's disease
Ugbode, C., Hu, Y., Whalley, B., Peers, C., Rattray, M., & Dallas, M. L. (2017) · Biochemical Journal · doi:10.1042/bcj20160505 · Cited by 25
Pan, X., Zz, L., Gg, J., Lp, W., Cm, B., Yl, W., Chen, M. F., & Li, W. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105417 · Cited by 26
GLUT1 is redundant in hypoxic and glycolytic nucleus pulposus cells of the intervertebral disc
Johnston, S. N., Silagi, E. S., Madhu, V., Nguyen, D. H., Shapiro, I. M., & Risbud, M. V. (2023) · JCI Insight · doi:10.1172/jci.insight.164883 · Cited by 25
Genome-wide analysis reveals molecular convergence underlying domestication in 7 bird and mammals
Hou, Y., Qi, F., Bai, X., Ren, T., Shen, X., Chu, Q., Zhang, X., & Lu, X. (2020) · BMC Genomics · doi:10.1186/s12864-020-6613-1 · Cited by 27
Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
Valenza, M., Facchinetti, R., Menegoni, G., Steardo, L., & Scuderi, C. (2021) · Biomolecules · doi:10.3390/biom11040600 · Cited by 25
Contrasting Metabolic Insufficiency in Aging and Dementia
Turner, D. A. (2021) · Aging and Disease · doi:10.14336/ad.2021.0104 · Cited by 25
Fareed, M. M., Qasmi, M., Aziz, S., Völker, E., Förster, C. Y., & Shityakov, S. (2022) · Biomolecules · doi:10.3390/biom12101452 · Cited by 25
Glucose Tightly Controls Morphological and Functional Properties of Astrocytes
Lee, C.-Y., Dallérac, G. M., Ezan, P., Anděrová, M., & Rouach, N. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00082 · Cited by 25
Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium
D'Arrigo, J. S. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.12.002 · Cited by 27
Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism
Cho, S., Lee, H., & Seo, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02297-x · Cited by 25
Maggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Analysis of shared underlying mechanism in neurodegenerative disease
Butler, R., Bradford, D. R., & Rodgers, K. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1006089 · Cited by 24
Unveiling the hidden connection: the blood-brain barrier’s role in epilepsy
Han, J., Wang, Y., Wei, P., Lu, D., & Shan, Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1413023 · Cited by 25
Does Diet Have a Role in the Treatment of Alzheimer's Disease?
Thelen, M., & Brown‐Borg, H. M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.617071 · Cited by 24
Goncalves, A., & Antonetti, D. A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00386-0 · Cited by 22
Oliveira, T. P. D., Morais, A. L. B., dos Reis, P. L. B., Palotás, A., & Vieira, L. B. (2023) · Metabolites · doi:10.3390/metabo14010025 · Cited by 24
Redox imbalance and metabolic defects in the context of Alzheimer disease
Domenico, F. D., Lanzillotta, C., & Marzia Perluigi, A. (2024) · FEBS Letters · doi:10.1002/1873-3468.14840 · Cited by 22
Blood brain barrier-on-a-chip to model neurological diseases
Reshma, S. C., Megha, K. B., Amir, S., Rukhiya, S., & Mohanan, P. V. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104174 · Cited by 23
Down-Regulated Drebrin Aggravates Cognitive Impairments in a Mouse Model of Alzheimer’s Disease
Liu, Y., Xu, Y., Zhang, L., Huang, L., Yü, P., Zhu, H., Deng, W., & Qin, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040800 · Cited by 23
Deletion of GLUT1 in mouse lens epithelium leads to cataract formation
Swarup, A., Bell, B. A., Du, J., Han, J. Y. S., Soto, J. E., Abel, E. D., Bravo‐Nuevo, A., FitzGerald, P. G., Peachey, N. S., & Philp, N. J. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.03.021 · Cited by 24
Self-citationPage, S., Patel, R., Raut, S., & Al-Ahmad, A. J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.009 · Cited by 23
Endothelial DR6 in blood-brain barrier malfunction in Alzheimer’s disease
Huang, X., Qi, J., Su, Y., Zhou, Y., Wang, Q., Huang, T., Xue, D., Zeng, Y., Verkhratsky, A., Zhou, B., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06639-0 · Cited by 23
Andrographolide restores glucose uptake in rat hippocampal neurons
Gherardelli, C., Cisternas, P., Gutiérrez, J., Martínez, M., & Inestrosa, N. C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15229 · Cited by 21
Asante, I., Louie, S. G., & Yassine, H. N. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14907 · Cited by 23
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25
Zhou, Q., Zheng, H. X., Chen, J., Li, C., Du, Y., Xia, H., & Gao, H. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0274-7 · Cited by 22
Liu, B., Bai, W., Ou, G., & Zhang, J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00644 · Cited by 21
Therapies for Alzheimer’s disease: a metabolic perspective
Domingues, R., Pereira, C., Cruz, M. T., & Silva, A. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.01.011 · Cited by 21
Cooperation between neurovascular dysfunction and Aβ in Alzheimer’s disease
Wang, N., Yang, X., Zhao, Z., Liu, D., Wang, X., Tang, H., Zhong, C., Chen, X., Chen, W. K., & Meng, Q. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1227493 · Cited by 22
Self-citationMa, Y., Sun, W., Bai, J., Gao, F., Ma, H., Liu, H., Hu, J., Xu, C., Zhang, X., Liu, Z., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14613 · Cited by 22
Contributions of Drug Transporters to Blood-Brain Barriers
Liu, L., & Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_9 · Cited by 21
Vascular endothelial cells: a fundamental approach for brain waste clearance
Wei, H., Jiang, H., Zhou, Y., Xiao, X., Zhou, C., & Ji, X. (2022) · Brain · doi:10.1093/brain/awac495 · Cited by 20
Abdullahi, A., Wong, T. W. L., & Ng, S. S. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102202 · Cited by 21
Cogill, S. A., Lee, J.-H., Jeon, M., Kim, D.-G., & Chang, Y. (2024) · Cells · doi:10.3390/cells13100789 · Cited by 20
The blood–brain barrier as a treatment target for neurodegenerative disorders
Rust, R., Sagare, A. P., Zhang, M., Zloković, B. V., & Kisler, K. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2480654 · Cited by 21
Self-citationMantle, J. L., & Lee, K. H. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26967 · Cited by 20
Joseph, C. R. (2020) · Biomedicines · doi:10.3390/biomedicines8070228 · Cited by 20
How endothelial cell metabolism shapes blood–brain barrier integrity in neurodegeneration
Wang, J., Chen, Y., Chen, S., Mu, Z., & Chen, J. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1623321 · Cited by 19
The Breakdown of Neurovascular Barriers: Molecular Mechanisms of Tight Junction Dysfunction
Gopal, S. S., Kaur, M., Lanzkron, S., & Srivastava, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05592-z · Cited by 20
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 20
The blood-brain barrier in health, neurological diseases, and COVID-19
Chen, J., Tan, R., Mo, Y., & Zhang, J. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.03.003 · Cited by 19
Harrison, M. A. A., Morris, S. L., Rudman, G. A., Rittenhouse, D. J., Monk, C. H., Sakamuri, S. S. V. P., Jones, M., Hasan, M. M., Khatun, M. S., Wang, H., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.12.033 · Cited by 19
Li, S., Meng, C., Hao, Q., Zhou, R., Dai, L., Guo, Y., Zhao, S., Zhou, X., Lou, C., Xu, J., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122537 · Cited by 19
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 19
Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects
Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21
Neuronutrition: An Emerging Concept
Topçuoğlu, M. A., & Arsava, E. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-53171-7_10 · Cited by 19
Ruze, R., Xu, Q., Liu, G., Li, Y., Chen, W., Cheng, Z., Xiong, Y., Liu, S., Zhang, G., Hu, S., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00126.2021 · Cited by 19
Ishida, N., Saito, M., Sato, S., Tezuka, Y., Sanbe, A., Taira, E., & Hirose, M. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.869 · Cited by 20
Williams, L. M., Fujimoto, T., Weaver, R. R., Logsdon, A. F., Wilson, M., Evitts, K. M., Young, J. E., Banks, W. A., & Erickson, M. A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00307-1 · Cited by 19
Gao, R., Gao, Y., Su, W., & Wang, R. (2025) · Aging and Disease · doi:10.14336/ad.2024.1629 · Cited by 18
Jin, Y., Kim, T., & Kang, H. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114145 · Cited by 18
Diao, X., Han, H., Li, B., Guo, Z., Fu, J. F., & Wu, W. (2023) · Marine Drugs · doi:10.3390/md21070406 · Cited by 17
Chen, F., He, Y., Wang, P., Wei, P., Feng, H., Rao, Y., Shi, J., & Tian, J. (2018) · International Journal of Immunopathology and Pharmacology · doi:10.1177/2058738418780066 · Cited by 18
Association of microbiota-derived propionic acid and Alzheimer’s disease; bioinformatics analysis
Aliashrafi, M., Nasehi, M. M., Zarrindast, M., Joghataei, M. T., Zali, H., & Siadat, S. D. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00564-7 · Cited by 18
Ren, C., Liu, Y., Stone, C., Li, N., Li, S., Li, H., Cheng, Z., Hu, J., Li, W., Jin, K., et al. (2021) · Aging and Disease · doi:10.14336/ad.2020.1125 · Cited by 18
Krishnan, S., Chang, A. C., Stoltz, B. M., & Prasadarao, N. V. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw306 · Cited by 18
Ye, Y., Chai, S.-F., Li, X.-R., Wu, M., Cai, H.-Y., & Wang, Z.-J. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01288-2 · Cited by 18
Anti-NMDAR antibodies, the blood–brain barrier, and anti-NMDAR encephalitis
Gong, X., Wang, N., Zhu, H., Tang, N., Wu, K., & Meng, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1283511 · Cited by 18
Bhat, N. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150098 · Cited by 18
Brain Endothelial Cells: Metabolic Flux and Energy Metabolism
McDonald, C., Blankenheim, Z. J., & Drewes, L. R. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_494 · Cited by 17
Metadata
- Authors
- Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., Sullivan, J. S., Zhao, Z., Meiselman, H. J., Wenby, R. B., Soto, J., Abel, E. D., Makshanoff, J., Zuniga, E., De Vivo, D. C., & Zlokovic, B. V.
- Affiliations
- University of Southern California (US)
- Tokyo Medical and Dental University (JP)
- University of Rochester Medicine (US)
- University of Iowa (US)
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2015-03-02
- Volume
- 18
- Issue
- 4
- Pages
- 521-530
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC4734893
- OpenAlex
- W1974266381
- Cited by
- 689
- References
- 63
- Citations by year
- 2026: 65 · 2025: 72 · 2024: 65 · 2023: 62 · 2022: 79 · 2021: 78 · 2020: 62 · 2019: 49 · 2018: 52 · 2017: 47 · 2016: 38 · 2015: 20
- FWCI
- 27.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Southern California
- National Institutes of Health
- National Institute on Aging (R01AG023084, R01AG039452, R37AG023084, AG039452, RF1AG039452, AG023084)
- National Heart, Lung, and Blood Institute (U01HL087947)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092065)
- National Institute of Neurological Disorders and Stroke (NS034467, R37NS034467, R01NS034467)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- GLUT1, Alzheimer's disease, blood-brain barrier, brain endothelium, amyloid-beta, amyloid-beta clearance, glucose transport, neurodegeneration, cerebrovascular dysfunction, cognitive impairment, therapeutic target
- MeSH terms
- Alzheimer Disease, Animals, Blood-Brain Barrier, Cerebrovascular Circulation, Disease Models, Animal, Endothelium, Vascular, Mice, Inbred C57BL, Mice, Transgenic, Amyloid beta-Peptides, Glucose Transporter Type 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
